Signaling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction

EMBO Journal

Volumn 15, Issue 17, 1996, Pages 4485-4496

  Luo, Kunxin ^a   Lodish, Harvey F ^b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

EpoR TGF R chimeric receptor; Growth inhibition; Serine; Signal transduction; TGF receptors; Threonine kinase

Indexed keywords

CELL SURFACE RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CHIMERA; CONTROLLED STUDY; CYTOPLASM; DIMERIZATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029792338     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00826.x     Document Type: Article

References (47)

1. Barber, D.L., DeMartino, J.C., Showers, M.O. and D'Andrea, A.D. (1994) A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol. Cell. Biol., 14, 2257-2265.
2. Bassing, C.H., Howe, D.J., Segarini, P.R., Donahoe, P.K. and Wang, X.F. (1994a) A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J. Biol. Chem., 269, 14861-14864.
3. Bassing, C.H., Yingling, J.M., Howe, D.J., Wang, T., He, W.W., Gustafson, M.L., Shah, P., Donahoe, P.K. and Wang, X.F. (1994b) A transforming growth factor β type I receptor that signals to activate gene expression. Science, 263, 87-89.
4. Chen, F. and Weinberg, R.A. (1995) Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl Acad. Sci. USA, 92, 1565-1569.
5. Chen, R.H. and Derynck, R. (1994) Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem., 269, 22868-22874.
6. Chen, R.H., Moses, H.L., Maruoka, E.M., Derynck, R. and Kawabata, M. (1995) Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J. Biol. Chem., 270, 12235-12241.
7. Contreras, M.A., Bale, W.F. and Spar, I.L. (1983) Iodine monochloride (ICI) iodination techniques. Methods Enzymol., 92, 277-292.
8. Cunningham, B.C., Ultsch, M., De Vos, A.M., Mulkerrin, M.G., Clauser, K.R. and Wells, J.A. (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science, 254, 821-825.
9. D'Andrea, A.D., Lodish, H.F. and Wong, G.G. (1989) Expression cloning of the murine erythropoietin receptor. Cell, 57, 277-285.
10. de Vos, A.M., Ultsch, M. and Kossiakoff, A.A. (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science, 255, 306-312.
11. Dickson, M.C., Martin, J.S., Cousins, F.M., Kulkarni, A.B., Karlsson, S. and Akhurst, R.J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development, 121, 1845-1854.
12. Dong, F. et al. (1994) Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl Acad. Sci. USA, 91, 4480-4484.
13. Elliott, S., Lorenzini, T., Yanagihara, D., Elliott, G. and Chang, D. (1995) Isolation and characterization of anti RHuEPO receptor monoclonal antibodies that activate the EPO receptor. Exp. Hematol., 23, 828.
14. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.H. and Miyazono, K. (1993) Cloning of a TGF β type I receptor that forms a heteromeric complex with the TGF β type II receptor. Cell, 75, 681-692.
15. Fuh, G., Cunningham, B.C., Fukunaga, R., Nagata, S., Goeddel, D.V. and Wells, J.A. (1992) Rational design of potent antagonists to the human growth hormone receptor. Science, 256, 1677-1680.
16. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551
17. Henis, Y.I., Moustakas, A., Lin, H.Y. and Lodish, H.F. (1994) The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol., 126, 139-154.
18. Kadin, M.E., Cavaille-Coll, M.W., Gertz, R., Massague, J., Cheifetz, S. and George, D. (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl Acad. Sci. USA, 91, 6002-6006.
19. Klingmuller, U., Lorenz, U., Cantley, L.C, Neel, B.G. and Lodish, H.F. (1995) Specific recruitment of SH-PTPI to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell, 80, 729-738.
20. Kulkarni, A.B. et al. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Aci. USA, 90, 770-774.
21. Li, J.P., D'Andrea, A.D., Lodish, H.F. and Baltimore, D. (1990) Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature, 343, 762-764.
22. Lin, H.Y., Moustakas, A., Knaus, P., Wells, R.G., Henis, Y.I. and Lodish, H.F. (1995) The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor. J. Biol. Chem., 270, 2747-2754.
23. Lin, H.Y., Wang, X.F. Ng-Eaton, E., Weinberg, R.A. and Lodish, H.F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase [published erratum appears in Cell, 1992 Sep 18: 70(6): following 1068]. Cell, 68, 775-785.
24. Markowitz, S. et al. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338.
25. Martin, J.S., Dickson, M.C., Cousins, F.M., Kulkarni, A.B., Karlsson, S. and Akhurst, R.J. (1995) Analysis of homozygous TGF β1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis. Ann. N. Y. Acad Sci., 752, 300-308.
26. Miller, A.D. and Rosman, G.J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques, 7, 980-982.
27. Ming, M., Ewen, M.E. and Pereira, M.E.A. ( 1995) Trypanosome invasion of mammalian cells requires activation of the TGFβ signaling pathway. Cell, 82, 287-296.
28. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
29. Moustakas, A., Lin, H.Y, Henis, Y.I., Plamondon, J., O'Connor-McCourt, M.D. and Lodish, H.F. (1993) The transforming growth factor β receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem., 268, 22215-22218.
30. Moustakas, A., Takumi, T., Lin, H.Y. and Lodish, H.F. ( 1995) GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor β and activin-A. J. Biol. Chem., 270, 765-769.
31. Okadome, T., Yamashita, H., Franzen, P., Moren, A., Heldin, C.H. and Miyazono, K. (1994) Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J. Biol. Chem., 269, 30753-30756.
32. Pear, W.S., Nolan, G.R. Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
33. Pharr, P.N., Hankins, D., Hofbauer, A., Lodish, H.F. and Longmore, G.D. (1993) Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc. Natl Acad. Sci. USA, 90, 938-942.
34. Philo, J.S., Aoki, K.H., Arakawa, T. Owers Narhi, L. and Wen, J. (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry, 35, 1681-1691.
35. Roberts, A.B. and Sporn, M.B. (1990) The transforming growth factor-βs. In Roberts, A.B. and Sporn, M.B. (eds), Peptide Growth Factors and Their Receptors. Springer-Verlag, Heidelberg, pp. 421-472.
36. Rodriguez, C., Chen, F., Weinberg, R.A. and Lodish, H.F. (1995) Cooperative binding of transforming growth factor (TGF)-β 2 to the types I and II TGF-β receptors. J. Biol. Chem., 270, 15919-15922.
37. Shull, M.M. et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature, 359, 693-699.
38. Ventura, F., Doody, J., Liu, F., Wrana, J.L. and Massague, J. (1994) Reconstitution and transphosphorylation of TGF-β receptor complexes. EMBO J., 13, 5581-5589.
39. Vivien, D., Attisano, L., Wrana, J.L. and Massague, J. (1995) Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes. J. Biol. Chem., 270, 7134-7141.
40. Wang, X.F., Lin, H.Y., Ng-Eaton, E., Downward, J., Lodish, H.F. and Weinberg, R.A. (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell, 67, 797-805.
41. Watowich, S.S., Hilton, D.J. and Lodish, H.F. (1994) Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol., 14, 3535-3549.
42. Weis-Garcia, F. and Massagué, J. (1996) Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J., 15, 276-289.
43. Wieser, R., Wrana, J.L. and Massagué, J. (1995) GS domain mutations that constitutively activate TβR-1, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14, 2199-2208.
44. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F. and Massagué, J. (1992) TGF β signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014.
45. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F. and Massagué, J. (1994) Mechanism of activation of the TGF-β receptor. Nature, 370, 341-347.
46. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K. and Heldin, C.H. (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269, 20172-20178.
47. Yoshimura, A., Longmore, G. and Lodish, H.F. (1990) Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature, 348, 647-649.